Avantor, Inc. Common Stock (NY:AVTR)

15.34 +0.31 (+2.06%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Avantor, Inc. Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Why Avantor (AVTR) Shares Are Trading Lower Today

July 21, 2025

Shares of life sciences company Avantor (NYSE:AVTR) fell 8% in the afternoon session after the company announced that it has appointed Emmanuel Ligner as its new President and Chief Executive Officer,...

Via StockStory

3 Small-Cap Stocks Facing Headwinds

June 27, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

2 Profitable Stocks to Target This Week and 1 to Brush Off

June 13, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

3 Healthcare Stocks with Mounting Challenges

June 12, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

An Overview of Avantor's Earnings ↗

April 24, 2025

Via Benzinga

3 Cash-Producing Stocks with Mounting Challenges

June 03, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know

May 21, 2025

A number of stocks fell in the afternoon session after the major indices pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that...

Via StockStory

Topics Bonds Stocks

Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know

May 12, 2025

A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides...

Via StockStory

Topics Government Stocks World Trade

AVTR Q1 Earnings Call: CEO Transition and Margin Focus Amid Weak Market Conditions

May 12, 2025

Life sciences company Avantor (NYSE:AVTR) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 5.9% year on year to $1.58 billion. Its non-GAAP profit of $0.23 per share was in...

Via StockStory

Topics Economy World Trade

Q1 Earnings Highs And Lows: Avantor (NYSE:AVTR) Vs The Rest Of The Research Tools & Consumables Stocks

May 11, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Avantor (NYSE:AVTR) and the best and worst...

Via StockStory

Topics Economy

3 Small-Cap Stocks with Mounting Challenges

May 07, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

Goldman Sachs Downgrades Avantor As Shares Spiral 60% Since 2021: 'We Wrongly Assumed...' ↗

April 29, 2025

Avantor missed Q1 sales estimates and faced multiple analyst downgrades as concerns mount over growth, competition, and product performance.

Via Benzinga

Demystifying Avantor: Insights From 16 Analyst Reviews ↗

April 29, 2025

Via Benzinga

Amazon.com To $253? Here Are 10 Top Analyst Forecasts For Tuesday ↗

April 29, 2025

Via Benzinga

Avantor Analysts Cut Their Forecasts After Q1 Results ↗

April 28, 2025

Via Benzinga

3 Hated Stocks in the Doghouse

April 28, 2025

Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.

Via StockStory

This Eli Lilly Analyst Turns Bearish; Here Are Top 4 Downgrades For Monday ↗

April 28, 2025

Via Benzinga

Why Avantor (AVTR) Shares Are Falling Today

April 25, 2025

Shares of life sciences company Avantor (NYSE:AVTR) fell 21.2% in the afternoon session after the company reported a weak first-quarter 2025 performance, as its organic revenue and total sales both...

Via StockStory

Topics Artificial Intelligence

Avantor Sees Steady Earnings, Plans Leadership Change And Strategy Shift ↗

April 25, 2025

Avantor matched EPS expectations but missed revenue targets and cut its outlook as its CEO steps down and cost-saving plans ramp up.

Via Benzinga

Avantor (NYSE:AVTR) Misses Q1 Revenue Estimates

April 25, 2025

Life sciences company Avantor (NYSE:AVTR) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 5.9% year on year to $1.58 billion. Its non-GAAP profit of $0.23 per share was...

Via StockStory

Topics Economy

Earnings Scheduled For April 25, 2025 ↗

April 25, 2025

Via Benzinga

Earnings To Watch: Avantor (AVTR) Reports Q1 Results Tomorrow

April 24, 2025

Life sciences company Avantor (NYSE:AVTR) will be reporting earnings tomorrow before market open. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence Economy World Trade

Reflecting On Research Tools & Consumables Stocks’ Q4 Earnings: Agilent (NYSE:A)

April 18, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Agilent (NYSE:A) and its peers.

Via StockStory

Topics Economy

Q4 Rundown: Avantor (NYSE:AVTR) Vs Other Research Tools & Consumables Stocks

April 10, 2025

Let’s dig into the relative performance of Avantor (NYSE:AVTR) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season.

Via StockStory

Topics Economy

A Look Back at Research Tools & Consumables Stocks’ Q4 Earnings: Mettler-Toledo (NYSE:MTD) Vs The Rest Of The Pack

April 08, 2025

Let’s dig into the relative performance of Mettler-Toledo (NYSE:MTD) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season.

Via StockStory

Topics Economy

3 Reasons AVTR is Risky and 1 Stock to Buy Instead

April 04, 2025

Shareholders of Avantor would probably like to forget the past six months even happened. The stock dropped 38.1% and now trades at $15.67. This was partly due to its softer quarterly results and might...

Via StockStory

3 Value Stocks in the Doghouse

March 28, 2025

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few...

Via StockStory

Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch

March 28, 2025

Let’s dig into the relative performance of Bio-Techne (NASDAQ:TECH) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season.

Via StockStory

Topics Economy

3 Healthcare Stocks Walking a Fine Line

March 20, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

Research Tools & Consumables Stocks Q4 Recap: Benchmarking Waters Corporation (NYSE:WAT)

March 20, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the research tools & consumables industry, including Waters Corporation (NYSE:WAT) and its peers.

Via StockStory

Topics Economy

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.